These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21677915)

  • 21. Maturity-onset diabetes of the young (MODY): an update.
    Anık A; Çatlı G; Abacı A; Böber E
    J Pediatr Endocrinol Metab; 2015 Mar; 28(3-4):251-63. PubMed ID: 25581748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proposed mechanism for a novel insertion/deletion frameshift mutation (I414G415ATCG-->CCA) in the hepatocyte nuclear factor 1 alpha (HNF-1 alpha) gene which causes maturity-onset diabetes of the young (MODY).
    Ellard S; Bulman MP; Frayling TM; Shepherd M; Hattersley AT
    Hum Mutat; 2000 Sep; 16(3):273. PubMed ID: 10980542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic Confirmation Rate in Clinically Suspected Maturity-Onset Diabetes of the Young.
    Brahm AJ; Wang G; Wang J; McIntyre AD; Cao H; Ban MR; Hegele RA
    Can J Diabetes; 2016 Dec; 40(6):555-560. PubMed ID: 27634015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low prevalence of MODY2 and MODY3 mutations in Brazilian individuals with clinical MODY phenotype.
    Furuzawa GK; Giuffrida FM; Oliveira CS; Chacra AR; Dib SA; Reis AF
    Diabetes Res Clin Pract; 2008 Sep; 81(3):e12-4. PubMed ID: 18672310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maturity-onset diabetes of the young (MODY), MODY genes and non-insulin-dependent diabetes mellitus.
    Velho G; Froguel P
    Diabetes Metab; 1997 Mar; 23 Suppl 2():34-7. PubMed ID: 9162575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetics of type 2 diabetes mellitus.
    Malecki MT
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S10-21. PubMed ID: 15955369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Missense glucokinase mutation in maturity-onset diabetes of the young and mutation screening in late-onset diabetes.
    Stoffel M; Patel P; Lo YM; Hattersley AT; Lucassen AM; Page R; Bell JI; Bell GI; Turner RC; Wainscoat JS
    Nat Genet; 1992 Oct; 2(2):153-6. PubMed ID: 1303265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Management of the MODY type diabetes].
    Timsit J; Velho G
    Journ Annu Diabetol Hotel Dieu; 2001; ():151-8. PubMed ID: 11565457
    [No Abstract]   [Full Text] [Related]  

  • 29. Genetic and clinical characteristics of maturity-onset diabetes of the young.
    Giuffrida FM; Reis AF
    Diabetes Obes Metab; 2005 Jul; 7(4):318-26. PubMed ID: 15955117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1).
    Yamagata K; Furuta H; Oda N; Kaisaki PJ; Menzel S; Cox NJ; Fajans SS; Signorini S; Stoffel M; Bell GI
    Nature; 1996 Dec; 384(6608):458-60. PubMed ID: 8945471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maturity onset diabetes of the young and pregnancy.
    Colom C; Corcoy R
    Best Pract Res Clin Endocrinol Metab; 2010 Aug; 24(4):605-15. PubMed ID: 20832739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three novel missense mutations in the glucokinase gene (G80S; E221K; G227C) in Italian subjects with maturity-onset diabetes of the young (MODY). Mutations in brief no. 162. Online.
    Guazzini B; Gaffi D; Mainieri D; Multari G; Cordera R; Bertolini S; Pozza G; Meschi F; Barbetti F
    Hum Mutat; 1998; 12(2):136. PubMed ID: 10694920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molecular background and clinical characteristics of autosomal dominant type 2 diabetes mellitus].
    Małecki M; Krolewski AS
    Przegl Lek; 2000; 57 Suppl 3():13-8. PubMed ID: 11293229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic polymorphisms in diabetes: influence on therapy with oral antidiabetics.
    Glamočlija U; Jevrić-Čaušević A
    Acta Pharm; 2010 Dec; 60(4):387-406. PubMed ID: 21169132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of new mutation in maturity-onset diabetes of the young type 3 (MODY 3) responsive to a low dose of sulphonylurea.
    Jesić MD; Sajić S; Jesić MM; Maringa M; Micić D; Necić S
    Diabetes Res Clin Pract; 2008 Jul; 81(1):e1-3. PubMed ID: 18433912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An infant with combination gene mutations for Monogenic Diabetes of Youth (MODY) 2 and 4, presenting with Diabetes Mellitus Requiring Insulin (DMRI) at 8 months of age.
    Odem J; Munzinger E; Violand S; Van Morlan A; Rife D; Bachrach B
    Pediatr Diabetes; 2009 Dec; 10(8):550-3. PubMed ID: 19515026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a new mutation in the hepatocyte nuclear factor-1alpha gene in a Polish family with early-onset type 2 diabetes mellitus.
    Malecki MT; Klupa T; Frey J; Cyganek K; Galicka-Stankowska D; Wanic K; Sieradzki J
    Diabetes Nutr Metab; 2001 Oct; 14(5):288-91. PubMed ID: 11806470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel nonsense mutation in GCK exon 9 co-segregates with diabetes phenotype.
    Knebel B; Jacob S; Boxberg CV; Müller-Wieland D; Kotzka J
    Exp Clin Endocrinol Diabetes; 2004 Jun; 112(6):298-301. PubMed ID: 15216446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-penetrance in a MODY 3 family with a mutation in the hepatic nuclear factor 1alpha gene: implications for predictive testing.
    Miedzybrodzka Z; Hattersley AT; Ellard S; Pearson D; de Silva D; Harvey R; Haites N
    Eur J Hum Genet; 1999 Sep; 7(6):729-32. PubMed ID: 10482964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [MODY].
    Sasaki A; Horikawa Y; Takeda J
    Nihon Rinsho; 2006 Sep; Suppl 3():54-8. PubMed ID: 17022499
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.